1. 15‐Deoxy‐Δ12,14‐prostaglandin J2 binds and inactivates STAT3 via covalent modification of cysteine 259 in H‐Ras‐transformed human breast epithelial cells
   Su‐Jung Kim et al, 2021, FEBS Letters CrossRef
2. Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma
   Carmen Salguero-Aranda et al, 2022, Cancers CrossRef
3. 15-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cells
   Zahirrah BM. Rasheed et al, 2022, Frontiers in Endocrinology CrossRef
4. Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
   Ainsley Mike Antao et al, 2020, Cancers CrossRef
5. Resveratrol suppresses proliferation and induces apoptosis of uterine sarcoma cells by inhibiting the Wnt signaling pathway
   Ayuka Mineda et al, 2019, Experimental and Therapeutic Medicine CrossRef
6. Biomaterial strategies to replicate gynecological tissue
   Ines Cadena et al, 2021, Biomaterials Science CrossRef
7. 15d-PGJ2 Promotes ROS-Dependent Activation of MAPK-Induced Early Apoptosis in Osteosarcoma Cell In Vitro and in an Ex Ovo CAM Assay
   Mateja Mikulčić et al, 2021, International Journal of Molecular Sciences CrossRef
8. E7050 Suppresses the Growth of Multidrug-Resistant Human Uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways
   Tsung-Teng Huang et al, 2023, International Journal of Molecular Sciences CrossRef